Affidea Group and Reset Health Team Up for Healthier Futures
Affidea is proud to introduce the Roczen platform from Reset Health, aimed at tackling obesity and type 2 diabetes through personalized care and advanced GLP-1 medications. This initiative aligns with Affidea's commitment to improving health outcomes for patients throughout its network.
Collaboration for Effective Health Solutions
In an exciting development, Affidea, a prominent pan-European offering community-based clinics and advanced diagnostic services, has formed a strategic partnership with Reset Health. This collaboration focuses on the implementation of the Roczen platform, a digital care model that provides doctor-led support for managing obesity and type 2 diabetes effectively.
What the Roczen Platform Offers
The Roczen platform will be introduced across Affidea’s facilities, providing patients with access to a comprehensive, clinically-proven care pathway. This pathway is data-driven, utilizing advanced analytics and evidence-based practices to enhance health management in addressing obesity and its related chronic conditions.
Key features of this innovative solution include:
- A complete support pathway tailored for patients.
- Ongoing tracking of vital health metrics, facilitating timely interventions.
- Custom treatment plans that consider real-time patient data and individual health needs.
- Direct communication channels between patients and healthcare providers for improved management and support.
- Guidance on sustainable lifestyle changes, including diet, exercise, and mental health.
- Access to GLP-1 medications for eligible patients to support chronic disease management.
A Step Forward in Patient-Centric Care
Affidea's partnership with Reset Health signifies a major advancement in addressing the rising demand for efficient weight and diabetes management solutions. This initiative reflects Affidea's ongoing mission to deliver cutting-edge, patient-focused care options, ensuring patients have access to innovative therapeutic choices, including GLP-1 medications.
By merging digital therapeutics with traditional healthcare support, Affidea clinics will offer personalized, accessible, and cost-effective care, aimed at empowering individuals to manage their health challenges while minimizing long-term health risks.
Voices from Leadership
Dr. Charles Niehaus, Executive Director for Affidea Group, expressed his enthusiasm: "At Affidea, our goal is to provide top-tier care tailored to our patients' specific needs. The Roczen platform we are launching enables us to present a clinically validated method for handling weight and diabetes care, targeting two critical health challenges today. By implementing personalized and data-driven interventions, we aim to empower our patients to take charge of their health better and enhance their overall quality of life."
Dr. David Wong, Chairman at Reset Health, shared his thoughts: "We are thrilled to partner with Affidea and lead the way in delivering high-caliber, clinically proven weight management and diabetes support across various regions. With our Roczen platform, we intend to provide personalized care to people struggling with obesity and type 2 diabetes, improving their experience and engagement for superior health outcomes."
The Growing Issue of Obesity
Current statistics on obesity present a pressing challenge. Numerous health organizations have reported alarming figures regarding obesity rates, indicating that nearly 60% of adults are overweight, and a significant portion classified as obese. Furthermore, projections suggest that by a certain year, obesity rates in adults may escalate further, possibly affecting 30% of the population.
The relationship between obesity and type 2 diabetes is stark, with a considerable percentage of individuals diagnosed with diabetes being either overweight or obese. Additional health complications linked to obesity include increased risk of sleep apnea, joint problems, and mental health issues.
The Role of GLP-1 Medications
Integrating access to GLP-1 medications allows for a more comprehensive management of chronic diseases such as obesity and diabetes. These medications, accompanied by personalized lifestyle interventions through the Roczen platform, offer significant health benefits for individuals facing these challenges.
About Affidea
Affidea is a well-established leader in providing community-based polyclinics, diagnostics, and specialized medical services across Europe. Founded in 1991, the company operates approximately 380 centers in multiple countries and serves nearly 14 million patients annually. Known for its emphasis on patient safety, Affidea has garnered numerous accolades, becoming the most awarded diagnostic imaging provider on the continent.
About Reset Health
Reset Health is a forward-thinking digital health company that emphasizes scalable clinical solutions and personalized lifestyle interventions. Its digital platform and care model, Roczen, is specifically designed to support patients managing obesity and associated health challenges. Reset Health collaborates with various stakeholders, including governments and healthcare systems, to deliver effective solutions to over half a million individuals.
Frequently Asked Questions
What is the Roczen platform?
The Roczen platform is a digital care model designed by Reset Health to provide personalized, doctor-led management for obesity and type 2 diabetes.
How will Affidea patients benefit from this collaboration?
Patients will gain access to a comprehensive, data-driven care strategy that improves health outcomes and offers personalized treatment plans based on their individual needs.
What types of support are included in the Roczen platform?
The platform includes continuous health tracking, direct communication with healthcare providers, and access to GLP-1 medications for eligible patients.
Why is addressing obesity important?
Obesity is linked to various serious health issues, including type 2 diabetes, heart disease, and mental health disorders, making its management crucial for improving public health.
How does Affidea ensure high-quality care?
Affidea has a robust infrastructure that emphasizes patient safety and care excellence, recognized by numerous awards and quality accreditations.
